文献速递急性肾损伤

血管内动脉瘤修复(EVAR)与经导管主动脉瓣置换(TAVR)相关急性肾损伤

Endovascular aneurysm repair (EVAR)- and transcatheter aortic valve replacement (TAVR)-associated acute kidney injury.
PubMed 文献 · Kidney Int · 2017-03-17

本文综述EVAR和TAVR术后急性肾损伤(AKI)的发生率、危险因素、病理生理、预后意义及治疗。两种手术常用于高危患者,术后AKI主要与对比剂肾毒性相关,肾内科医生越来越多遇到此类患者。

要点

  • EVAR和TAVR术后AKI主要与对比剂肾毒性相关。
  • 接受EVAR或TAVR的患者术前常存在多项AKI危险因素。
  • 综述总结了EVAR和TAVR相关AKI的发生率、危险因素、病理生理、预后及治疗。

核心结论

  • EVAR和TAVR术后AKI是重要并发症,可能影响死亡率、发病率及医疗费用,主要与对比剂肾毒性相关。

研究设计与样本

  • 综述,总结EVAR和TAVR相关AKI的现有数据。

主要发现

  • EVAR和TAVR术后AKI主要归因于对比剂肾毒性。
  • 接受EVAR或TAVR的患者术前常存在多项已确立的AKI危险因素。
  • 多项研究探讨了EVAR和TAVR术后AKI的发生率、危险因素及自然病程。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute kidney injury (AKI) after surgery or intervention is an important complication that may impact mortality, morbidity, and health care costs. Endovascular procedures are now performed routinely for a variety of pathologies that were traditionally treated with open surgery because randomized trials comparing endovascular and open surgery have shown at least equally good results and reduced complication and hospitalization rates with endovascular techniques. However, endovascular procedures have been associated with an increased risk for postoperative AKI, predominantly owing to contrast nephrotoxicity. Over the years, endovascular techniques have progressively been applied for the treatment of complex cardiovascular pathologies, and in recent years, nephrologists have increasingly encountered patients who developed AKI after endovascular aneurysm repair or transcatheter aortic valve replacement. These 2 procedures typically involve high-risk patients who have several established AKI risk factors prior to intervention. Several studies have investigated the incidence, risk factors, and natural course of AKI after endovascular aneurysm repair and transcatheter aortic valve replacement. This review summarizes current data on incidence, risk factors, pathophysiology, prognostic implications, and treatment of AKI associated with endovascular aneurysm replacement and transcatheter aortic valve replacement.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Jhaveri KD, Saratzis AN, Wanchoo R, et al. Endovascular aneurysm repair (EVAR)- and transcatheter aortic valve replacement (TAVR)-associated acute kidney injury. Kidney Int. 2017. PMID: 28318632. doi:10.1016/j.kint.2016.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。